These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10663532)

  • 1. Structure prediction of the dimeric neu/ErbB-2 transmembrane domain from multi-nanosecond molecular dynamics simulations.
    Sajot N; Genest M
    Eur Biophys J; 2000; 28(8):648-62. PubMed ID: 10663532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
    Sajot N; Genest M
    J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.
    Garnier N; Genest D; Duneau JP; Genest M
    Biopolymers; 1997 Aug; 42(2):157-68. PubMed ID: 9234995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study.
    Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer.
    Aller P; Voiry L; Garnier N; Genest M
    Biopolymers; 2005 Mar; 77(4):184-97. PubMed ID: 15660449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer.
    Garnier N; Crouzy S; Genest M
    J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane peptides from tyrosine kinase receptor. Mutation-related behavior in a lipid bilayer investigated by molecular dynamics simulations.
    Samna Soumana O; Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2005 Aug; 23(1):91-100. PubMed ID: 15918680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane interactions in the activation of the Neu receptor tyrosine kinase.
    Smith SO; Smith C; Shekar S; Peersen O; Ziliox M; Aimoto S
    Biochemistry; 2002 Jul; 41(30):9321-32. PubMed ID: 12135353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers.
    Sharpe S; Barber KR; Grant CW
    Biochemistry; 2000 May; 39(21):6572-80. PubMed ID: 10828974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
    Brandt-Rauf PW; Pincus MR; Monaco R
    J Protein Chem; 1995 Jan; 14(1):33-40. PubMed ID: 7779261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.
    Burke CL; Stern DF
    Mol Cell Biol; 1998 Sep; 18(9):5371-9. PubMed ID: 9710621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence dependence of BNIP3 transmembrane domain dimerization implicates side-chain hydrogen bonding and a tandem GxxxG motif in specific helix-helix interactions.
    Sulistijo ES; MacKenzie KR
    J Mol Biol; 2006 Dec; 364(5):974-90. PubMed ID: 17049556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into signal transduction: structural alterations in transmembrane helices probed by multi-1 ns molecular dynamics simulations.
    Duneau JP; Garnier N; Genest M
    J Biomol Struct Dyn; 1997 Dec; 15(3):555-72. PubMed ID: 9440002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE.
    Houliston RS; Hodges RS; Sharom FJ; Davis JH
    FEBS Lett; 2003 Jan; 535(1-3):39-43. PubMed ID: 12560075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor.
    Smith SO; Smith CS; Bormann BJ
    Nat Struct Biol; 1996 Mar; 3(3):252-8. PubMed ID: 8605627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains.
    Beevers AJ; Kukol A
    J Mol Graph Model; 2006 Oct; 25(2):226-33. PubMed ID: 16434222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transmembrane domain of the oncogenic mutant ErbB-2 receptor: a structure obtained from site-specific infrared dichroism and molecular dynamics.
    Beevers AJ; Kukol A
    J Mol Biol; 2006 Sep; 361(5):945-53. PubMed ID: 16889796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.
    Beevers AJ; Damianoglou A; Oates J; Rodger A; Dixon AM
    Biochemistry; 2010 Apr; 49(13):2811-20. PubMed ID: 20180588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
    Mendrola JM; Berger MB; King MC; Lemmon MA
    J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.